Ticker League

Operating Income for IDEXX Laboratories (IDXX)

Latest filings through · Reported

Metric

TTM

$1.41B

YoY change

+20.5%

5Y CAGR

+14.4%

Peak year (2025)

$1.36B

Operating Income history chart for IDEXX Laboratories (IDXX) from 1991 to 2025

Latest: $1.36B

Operating Income growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025

Latest: +20.5%

Operating Income history table for IDEXX Laboratories (IDXX) from 1991 to 2025

  • 2025$1.36B+20.5%
  • 2024$1.13B+2.8%
  • 2023$1.10B+22.1%
  • 2022$898.76M-3.6%
  • 2021$932.03M+34.2%
  • 2020$694.52M+25.6%
  • 2019$552.85M+12.5%
  • 2018$491.33M+19.0%
  • 2017$413.03M+17.9%
  • 2016$350.24M+16.8%
  • 2015$299.91M+15.2%
  • 2014$260.25M-2.4%
  • 2013$266.76M+1.6%
  • 2012$262.56M+11.1%
  • 2011$236.22M+15.9%
  • 2010$203.88M+15.9%
  • 2009$175.97M+2.0%
  • 2008$172.46M+26.6%
  • 2007$136.18M+6.4%
  • 2006$127.93M+10.9%
  • 2005$115.33M+6.8%
  • 2004$108.03M+34.4%
  • 2003$80.39M+22.1%
  • 2002$65.81M+16.4%
  • 2001$56.55M+6.2%
  • 2000$53.25M+13.8%
  • 1999$46.80M+60.8%
  • 1998$29.10M-761.4%
  • 1997−$4.40M-109.4%
  • 1996$47.00M+42.9%
  • 1995$32.90M+44.3%
  • 1994$22.80M+64.0%
  • 1993$13.90M+172.5%
  • 1992$5.10M+96.2%
  • 1991$2.60M—

Operating Income values are taken from IDEXX Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Income at IDEXX Laboratories (IDXX)

According to IDEXX Laboratories's latest reported financial statements, the company's current operating income (TTM) is $1.41B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of IDEXX Laboratories (IDXX) operating income is $1.36B – grew 20.5% year-over-year.

Through 2020–2025 (5 years), IDEXX Laboratories operating income delivered a +14.4% annualised rate; sustaining 3 straight years of year-over-year growth.

Across the available history, operating income reached its high of $1.36B in 2025 and its low of −$4.40M in 1997.

IDEXX Laboratories Operating Income by Year

IDEXX Laboratories Operating Income 2025: $1.36B

In 2025, IDEXX Laboratories reported operating income of $1.36B, grew 20.5% from 2024. This figure represents the highest annual value in the available history.

IDEXX Laboratories Operating Income 2024: $1.13B

IDEXX Laboratories operating income in 2024 was $1.13B, edged up 2.8% from 2023.

IDEXX Laboratories Operating Income 2023: $1.10B

2023's operating income for IDEXX Laboratories came in at $1.10B, grew 22.1% from 2022.

IDEXX Laboratories Operating Income 2022: $898.76M

IDEXX Laboratories posted operating income of $898.76M in 2022, edged down 3.6% below 2021.

IDEXX Laboratories Operating Income 2021: $932.03M

IDEXX Laboratories operating income in 2021 was $932.03M.

See more financial history for IDEXX Laboratories (IDXX).

Sector peers by Operating Income

Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest operating income

Frequently asked questions

IDEXX Laboratories (IDXX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation